Literature DB >> 24377034

Exit fluence analysis using portal dosimetry in volumetric modulated arc therapy.

Prabakar Sukumar1, Sriram Padmanaban1, Dhanabalan Rajasekaran1, Muniyappan Kannan2, Vivekanandan Nagarajan1.   

Abstract

AIM: In measuring exit fluences, there are several sources of deviations which include the changes in the entrance fluence, changes in the detector response and patient orientation or geometry. The purpose of this work is to quantify these sources of errors.
BACKGROUND: The use of the volumetric modulated arc therapy treatment with the help of image guidance in radiotherapy results in high accuracy of delivering complex dose distributions while sparing critical organs. The transit dosimetry has the potential of Verifying dose delivery by the linac, Multileaf collimator positional accuracy and the calculation of dose to a patient or phantom.
MATERIALS AND METHODS: The quantification of errors caused by a machine delivery is done by comparing static and arc picket fence test for 30 days. A RapidArc plan, created for the pelvis site was delivered without and with Rando phantom and exit portal images were acquired. The day to day dose variation were analysed by comparing the daily exit dose images during the course of treatment. The gamma criterion used for analysis is 3% dose difference and 3 mm distance to agreement with a threshold of 10% of maximum dose.
RESULTS: The maximum standard deviation for the static and arc picket fence test fields were 0.19 CU and 1.3 CU, respectively. The delivery of the RapidArc plans without a phantom shows the maximum standard deviation of 1.85 CU and the maximum gamma value of 0.59. The maximum gamma value for the RapidArc plan delivered with the phantom was found to be 1.2. The largest observed fluence deviation during the delivery to patient was 5.7% and the maximum standard deviation was 4.1 CU.
CONCLUSION: It is found from this study that the variation due to patient anatomy and interfraction organ motion is significant.

Entities:  

Keywords:  EPID; Exit fluence; Gamma evaluation; Portal dosimetry; RapidArc

Year:  2012        PMID: 24377034      PMCID: PMC3863274          DOI: 10.1016/j.rpor.2012.06.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  23 in total

1.  Three-dimensional dose reconstruction of breast cancer treatment using portal imaging.

Authors:  R J W Louwe; E M F Damen; M van Herk; A W H Minken; O Törzsök; B J Mijnheer
Journal:  Med Phys       Date:  2003-09       Impact factor: 4.071

2.  Experimental verification of a portal dose prediction model.

Authors:  W J C van Elmpt; S M J J G Nijsten; B J Mijnheer; A W H Minken
Journal:  Med Phys       Date:  2005-09       Impact factor: 4.071

3.  Comparison of dose distributions in IMRT planning using the gamma function.

Authors:  C Andenna; M Benassi; B Caccia; S Marzi; M Pedrini; C Zicari
Journal:  J Exp Clin Cancer Res       Date:  2006-06

4.  Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.

Authors:  L N McDermott; M Wendling; B van Asselen; J Stroom; J J Sonke; M van Herk; B J Mijnheer
Journal:  Med Phys       Date:  2006-10       Impact factor: 4.071

Review 5.  A literature review of electronic portal imaging for radiotherapy dosimetry.

Authors:  Wouter van Elmpt; Leah McDermott; Sebastiaan Nijsten; Markus Wendling; Philippe Lambin; Ben Mijnheer
Journal:  Radiother Oncol       Date:  2008-08-14       Impact factor: 6.280

6.  In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion.

Authors:  M Kroonwijk; K L Pasma; S Quint; P C Koper; A G Visser; B J Heijmen
Journal:  Radiother Oncol       Date:  1998-11       Impact factor: 6.280

7.  Portal dose image (PDI) prediction for dosimetric treatment verification in radiotherapy. I. An algorithm for open beams.

Authors:  K L Pasma; B J Heijmen; M Kroonwijk; A G Visser
Journal:  Med Phys       Date:  1998-06       Impact factor: 4.071

8.  Comparison of sources of exit fluence variation for IMRT.

Authors:  Joseph K Gardner; Luke Clews; J James Gordon; Song Wang; Peter B Greer; Jeffrey V Siebers
Journal:  Phys Med Biol       Date:  2009-09-04       Impact factor: 3.609

9.  The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations.

Authors:  Wouter van Elmpt; Sebastiaan Nijsten; Ben Mijnheer; André Dekker; Philippe Lambin
Journal:  Radiother Oncol       Date:  2007-12-03       Impact factor: 6.280

10.  The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy.

Authors:  Giorgia Nicolini; Eugenio Vanetti; Alessandro Clivio; Antonella Fogliata; Stine Korreman; Jiri Bocanek; Luca Cozzi
Journal:  Radiat Oncol       Date:  2008-09-09       Impact factor: 3.481

View more
  2 in total

1.  Commissioning and Acceptance Testing of the existing linear accelerator upgraded to volumetric modulated arc therapy.

Authors:  Ekambaram Varadharajan; Velayudham Ramasubramanian
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-06

2.  Clinical examples of 3D dose distribution reconstruction, based on the actual MLC leaves movement, for dynamic treatment techniques.

Authors:  Wojciech Osewski; Lukasz Dolla; Michał Radwan; Marta Szlag; Roman Rutkowski; Barbara Smolińska; Krzysztof Slosarek
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.